It is a chemicals and materials private limited company based in Hyderabad, Telangana, India, established in 1996.
1996 | Hyderabad, Telangana, India | AmalgamatedMadaus Pharmaceuticals Private Limited, a amalgamated private limited company, was established on 28 February 1996 in Hyderabad, Telangana, India. Engaging in chemical distribution & retail within the manufacturing sector, it holds CIN: U24230TG1996PTC124476. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹53.00 Cr and a paid-up capital of ₹33.00 Cr.
It upholds a compliant status. Employing 7 professional, Its leadership includes Ashutosh Ramchandra Rawal (Managing Director), Sarada Kalyani Bhagawati (Director). Past directors included Rohit Kochhar, Carlos Puigventos Fabro, Hanke Wohlers. It holds no open charges and ₹5.23 M settled loans. Its latest AGM occurred on 28 September 2018, with the balance sheet filed on 31 March 2018. It is based at Plot No. 564/A/22, Road No. 92, Jubilee Hills,, Hyderabad, Telangana, 500096.
U24230TG1996PTC124476
124476
28 February 1996
₹53.00 Cr
₹33.00 Cr
Roc Hyderabad
Unlisted
Amalgamated
Explore comprehensive insights into Madaus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashutosh Ramchandra Rawal | Managing Director | 07 Oct 2010 | Current |
| Sarada Kalyani Bhagawati | Director | 15 Sep 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Alternate Director | 07 May 2012 | Past |
| Pramod Abcsdd | Director | 12 Jul 2008 | Past |
| Pramod Abcsdd | Director | 07 May 2012 | Past |
| Pramod Abcsdd | Director | 25 Mar 2013 | Past |
| Pramod Abcsdd | Director | 19 Dec 2014 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Madaus Pharmaceuticals Private Limited, for the financial year ended 2018, experienced Minor drop in revenue, with a 8.52% decrease. The company also saw a substantial improvement in profitability, with a 49.11% increase in profit. The company's net worth moved up by a moderate rise of 9.08%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Madaus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹5,225,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Nov 1997 | Pharmazeutische Union Gmbh | ₹5.23 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Madaus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Madaus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Madaus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Madaus Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2018 as per latest MCA records. was completed.
The activity Madaus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Hyderabad. was completed.
The activity Siva Kiran Kuncham was appointed as a Company Secretary was appointed as a Company Secretary on 25 Sep 2017 & has been associated with this company since 8 years 2 months . was completed.
Progress on Sarada Kalyani Bhagawati was appointed as a Director was appointed as a Director on 15 Sep 2017 & has been associated with this company since 8 years 2 months . was documented.
Progress on A charge registered on 14 Nov 1997 via Charge ID 90156714 with Pharmazeutische Union Gmbh was fully satisfied on 08 Mar 2011. was documented.
The activity Ashutosh Ramchandra Rawal was appointed as a Managing Director was appointed as a Managing Director on 07 Oct 2010 & has been associated with this company since 15 years 1 month . was completed.
The CIN of Madaus Pharmaceuticals Private Limited is U24230TG1996PTC124476.
Madaus Pharmaceuticals Private Limited is headquartered at Plot No. 564/A/22, Road No. 92, Jubilee Hills,, Hyderabad, Telangana, 500096.
Madaus Pharmaceuticals Private Limited was incorporated on 28 February 1996.
The current directors of Madaus Pharmaceuticals Private Limited are
The primary industry of Madaus Pharmaceuticals Private Limited is Manufacturing.
Madaus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Madaus Pharmaceuticals Private Limited is ₹53.00 Cr, and the paid-up capital is ₹33.00 Cr.
The compliance status of Madaus Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX